Literature DB >> 12783598

Angiopoietins in angiogenesis and beyond.

Stelios Tsigkos1, Micheal Koutsilieris, Andreas Papapetropoulos.   

Abstract

The angiopoietin (Ang) family of growth factors includes four members, all of which bind to the endothelial receptor tyrosine kinase Tie2. Two of the Angs, Ang-1 and Ang-4, activate the Tie2 receptor, whereas Ang-2 and Ang-3 inhibit Ang-1-induced Tie2 phosphorylation. While genetic models have underscored the importance of Angs in the developing cardiovascular system, other studies have demonstrated that Ang-1 promotes endothelial cell survival, sprouting and tube formation. More recently, a new aspect of the biology of this class of growth factors has emerged, namely the ability of Ang-1 to reduce inflammation. This review presents an outline of Angs and their receptors, examining their structure, expression, signalling, regulation and biological significance and comments on the role and potential usefulness of Angs in medicine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783598     DOI: 10.1517/13543784.12.6.933

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  35 in total

1.  Endothelial progenitor cells homing and renal repair in experimental renovascular disease.

Authors:  Alejandro R Chade; Xiang-Yang Zhu; James D Krier; Kyra L Jordan; Stephen C Textor; Joseph P Grande; Amir Lerman; Lilach O Lerman
Journal:  Stem Cells       Date:  2010-06       Impact factor: 6.277

Review 2.  Switching off malignant pleural effusion formation-fantasy or future?

Authors:  Magda Spella; Anastasios D Giannou; Georgios T Stathopoulos
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

Review 3.  Antiangiogenic therapy in human gastrointestinal malignancies.

Authors:  J Heidemann; D G Binion; W Domschke; T Kucharzik
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

4.  Angiogenesis and multiple myeloma.

Authors:  Nicola Giuliani; Paola Storti; Marina Bolzoni; Benedetta Dalla Palma; Sabrina Bonomini
Journal:  Cancer Microenviron       Date:  2011-07-07

Review 5.  Aflibercept--a decoy VEGF receptor.

Authors:  Kristen K Ciombor; Jordan Berlin
Journal:  Curr Oncol Rep       Date:  2014-02       Impact factor: 5.075

6.  Mediators of angiogenesis and fibrosis in IgG4-related disease.

Authors:  Ilaria Puxeddu; Riccardo Capecchi; Federico Pratesi; Silvana Cianchetti; Antonio Tavoni; Paola Migliorini
Journal:  Clin Exp Med       Date:  2017-12-14       Impact factor: 3.984

7.  Leptin administered in physiological or pharmacological doses does not regulate circulating angiogenesis factors in humans.

Authors:  K N Aronis; K N Diakopoulos; C G Fiorenza; J P Chamberland; C S Mantzoros
Journal:  Diabetologia       Date:  2011-06-10       Impact factor: 10.122

8.  Angiopoietin-2 in experimental colitis.

Authors:  Vijay C Ganta; Walter Cromer; Ginny L Mills; James Traylor; Merilyn Jennings; Sarah Daley; Benjamin Clark; J Michael Mathis; Michael Bernas; Moheb Boktor; Paul Jordan; Marlys Witte; J Steven Alexander
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

9.  Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells.

Authors:  Efstathia Papageorgiou; Nea Pitulis; Menelaos Manoussakis; Peter Lembessis; Michael Koutsilieris
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

10.  Anti-angiogenic properties of a sulindac analogue.

Authors:  A Pyriochou; S Tsigkos; T Vassilakopoulos; T Cottin; Z Zhou; E Gourzoulidou; C Roussos; H Waldmann; A Giannis; A Papapetropoulos
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.